Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-06

Clinical Trial Update: A Study of YP05002 in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 study of YP05002 in healthy participants is currently recruiting to evaluate its potential for weight management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • YP05002

Snippet

Sponsor: Yaopharma Co., Ltd. | Conditions: Weight Management | Phase 1 | Status: RECRUITING